Cover Image
市場調查報告書

Immune Design Corp.的產品平台分析

Immune Design Corp. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 277767
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Immune Design Corp.的產品平台分析 Immune Design Corp. - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 33 Pages
簡介

Immune Design Corp.是總公司在美國的生物科技企業,藥物研發、開發癌症、感染疾病、過敏、自體免疫疾病等的治療用疫苗。擁有癌症免疫療法用醫藥品,及大流行性流感用疫苗等產品。

本報告提供Immune Design Corp. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Immune Design Corp. 的基本資料

  • Immune Design Corp. 概要
  • 主要資訊
  • 企業資料

Immune Design Corp. :R&D概要

  • 主要的治療範圍

Immune Design Corp. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Immune Design Corp. :開發中產品概況

  • 在臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段有的開發中產品
    • IND/CTA申請中的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式

Immune Design Corp. :藥物簡介

  • G-100
  • G-305
  • LV-305
  • (ID-LV305 + ID-G305)
  • G-103

Immune Design Corp. :開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型

Immune Design Corp. :最新的開發平台資訊

Immune Design Corp. :開發休止的計劃

Immune Design Corp. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07016CDB

Summary

Global Markets Direct's, 'Immune Design Corp. - Product Pipeline Review - 2015', provides an overview of the Immune Design Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Immune Design Corp. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Immune Design Corp.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Immune Design Corp.'s pipeline products

Reasons to buy

  • Evaluate Immune Design Corp.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Immune Design Corp. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Immune Design Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Immune Design Corp. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Immune Design Corp.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Immune Design Corp. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Immune Design Corp. Snapshot
    • Immune Design Corp. Overview
    • Key Information
    • Key Facts
  • Immune Design Corp. - Research and Development Overview
    • Key Therapeutic Areas
  • Immune Design Corp. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Immune Design Corp. - Pipeline Products Glance
    • Immune Design Corp. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Immune Design Corp. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Immune Design Corp. - Drug Profiles
    • (ID-LV305 + ID-G305)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • G-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • G-305
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LV-305
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • G-103
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Immune Design Corp. - Pipeline Analysis
    • Immune Design Corp. - Pipeline Products by Target
    • Immune Design Corp. - Pipeline Products by Route of Administration
    • Immune Design Corp. - Pipeline Products by Molecule Type
  • Immune Design Corp. - Recent Pipeline Updates
  • Immune Design Corp. - Dormant Projects
  • Immune Design Corp. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Immune Design Corp., Key Information
  • Immune Design Corp., Key Facts
  • Immune Design Corp. - Pipeline by Indication, 2015
  • Immune Design Corp. - Pipeline by Stage of Development, 2015
  • Immune Design Corp. - Monotherapy Products in Pipeline, 2015
  • Immune Design Corp. - Combination Treatment Modalities in Pipeline, 2015
  • Immune Design Corp. - Partnered Products in Pipeline, 2015
  • Immune Design Corp. - Partnered Products/ Combination Treatment Modalities, 2015
  • Immune Design Corp. - Out-Licensed Products in Pipeline, 2015
  • Immune Design Corp. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Immune Design Corp. - Phase I, 2015
  • Immune Design Corp. - Preclinical, 2015
  • Immune Design Corp. - Pipeline by Target, 2015
  • Immune Design Corp. - Pipeline by Route of Administration, 2015
  • Immune Design Corp. - Pipeline by Molecule Type, 2015
  • Immune Design Corp. - Recent Pipeline Updates, 2015
  • Immune Design Corp. - Dormant Developmental Projects,2015
  • Immune Design Corp., Other Locations

List of Figures

  • Immune Design Corp. - Pipeline by Top 10 Indication, 2015
  • Immune Design Corp. - Pipeline by Stage of Development, 2015
  • Immune Design Corp. - Monotherapy Products in Pipeline, 2015
  • Immune Design Corp. - Partnered Products in Pipeline, 2015
  • Immune Design Corp. - Pipeline by Top 10 Route of Administration, 2015
  • Immune Design Corp. - Pipeline by Top 10 Molecule Type, 2015
Back to Top